fibrous dysplasia
Information
- Disease name
- fibrous dysplasia
- Disease ID
- DOID:0080031
- Description
- "A bone remodeling disease that results_in the destruction of normal bone and replacing it with fibrous bone tissue." [url:http\://en.wikipedia.org/wiki/Fibrous_dysplasia_of_bone, url:http\://orthoinfo.aaos.org/topic.cfm?topic=a00083, url:http\://www.mayoclinic.com/health/fibrous-dysplasia/DS00991, url:http\://www.nlm.nih.gov/medlineplus/ency/article/001234.htm]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04931056 | Completed | A Post Market Clinical Follow-up Study on Biomet Microfixation HTR PEKK (Midface), Facial & Mandibular Plates. | October 1, 2021 | November 30, 2023 | |
| NCT04671719 | Completed | Determination of Circulating Autotaxin in Patients With GNAS or PTH Abnormalities | March 10, 2021 | January 11, 2023 | |
| NCT05406544 | Completed | Df-Life : Quality of Life in Patients With Fibrous Dysplasia | November 28, 2022 | May 2, 2023 | |
| NCT03231644 | Recruiting | Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry | October 31, 2016 | October 2026 | |
| NCT05966064 | Recruiting | Phase 4 | DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD) | June 13, 2023 | June 2025 |
| NCT05419050 | Recruiting | Phase 2 | Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia | October 12, 2022 | January 9, 2026 |
| NCT03520153 | Withdrawn | Characterization of Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome | August 7, 2018 | August 2021 |
- Disase is a (Disease Ontology)
- DOID:0080005
- Cross Reference ID (Disease Ontology)
- GARD:6444
- Cross Reference ID (Disease Ontology)
- ICDO:8818/0